Nuwellis, Inc. (NUWE)

Market Cap	809.30K
Revenue (ttm)	8.79M
Net Income (ttm)	-9.85M
Shares Out	113.83K
EPS (ttm)	-4.15
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	117,120
Open	7.98
Previous Close	8.24
Day's Range	6.73 - 8.34
52-Week Range	6.73 - 245.28
Beta	0.28
Analysts	Strong Buy
Price Target	17.00 (+139.1%)
Earnings Date	Aug 12, 2025

About NUWE

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through specialty healthcare distributors in Aust...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 38
• Stock Exchange: NASDAQ
• Ticker Symbol: NUWE
• Website: https://www.nuwellis.com

Financial Performance

In 2024, Nuwellis's revenue was $8.74 million, a decrease of -1.40% compared to the previous year's $8.86 million. Losses were -$10.62 million, -53.05% less than in 2023.

Analyst Summary

According to one analyst, the rating for NUWE stock is "Strong Buy" and the 12-month stock price target is $17.0.

Price Target

$17.0

(139.10% upside)

Analyst Consensus: Strong Buy